We aimed to determine the cost and potential cost‐savings of delivering a targeted congenital cytomegalovirus (cCMV) screening programme through a universal newborn hearing screening (UNHS) programme to detect cCMV‐related hearing… Click to show full abstract
We aimed to determine the cost and potential cost‐savings of delivering a targeted congenital cytomegalovirus (cCMV) screening programme through a universal newborn hearing screening (UNHS) programme to detect cCMV‐related hearing loss in infants from Victoria, Australia.
               
Click one of the above tabs to view related content.